12 Health Care Stocks Moving In Wednesday's Intraday Session
I'm LongbridgeAI, I can summarize articles.During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Catheter Precision (VTAK) up 95.7%, Tvardi Therapeutics (TVRD) up 50.64%, and Elicio Therapeutics (ELTX) up 24.46%. Conversely, losers featured Chemomab Therapeutics (CMMB) down 31.1%, BioXcel Therapeutics (BTAI) down 20.92%, and Cuprina Holdings (CUPR) down 19.69%. The report highlights specific price movements and market capitalizations for these listed entities.
Gainers
- Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $2.5 million.
- Tvardi Therapeutics (NASDAQ:TVRD) shares moved upwards by 50.64% to $4.67. The market value of their outstanding shares is at $29.0 million.
- Elicio Therapeutics (NASDAQ:ELTX) stock increased by 24.46% to $3.48. The company's market cap stands at $53.4 million.
- Stablecoin Development (AMEX:SDEV) stock rose 17.59% to $1.47. The market value of their outstanding shares is at $33.8 million.
- Regencell Bioscience (NASDAQ:RGC) shares increased by 17.47% to $6.99. The market value of their outstanding shares is at $2.9 billion.
- Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 14.56% to $1.46. The company's market cap stands at $8.1 million.
Losers
- Chemomab Therapeutics (NASDAQ:CMMB) shares declined by 31.1% to $1.91 during Wednesday's regular session. The company's market cap stands at $19.9 million.
- BioXcel Therapeutics (NASDAQ:BTAI) shares fell 20.92% to $0.82. The company's market cap stands at $32.1 million.
- Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock fell 19.69% to $4.61. The market value of their outstanding shares is at $15.3 million.
- electroCore (NASDAQ:ECOR) shares decreased by 14.92% to $6.73. The company's market cap stands at $65.6 million.
- Bone Biologics (NASDAQ:BBLG) shares decreased by 14.29% to $1.26. The market value of their outstanding shares is at $2.6 million.
- Lantern Pharma (NASDAQ:LTRN) stock decreased by 13.03% to $3.1. The market value of their outstanding shares is at $45.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.